Back to today’s briefing

Story perspectives

Revolutionary Injectable Drug Offers Hope Against Alzheimer’s

5/12/2025

48 10

Summary

Story summary

At Royal Melbourne Hospital, researchers are pioneering a groundbreaking injectable drug, remternetug, designed to delay the onset of Alzheimer’s in individuals aged 65-80 exhibiting early symptoms. This global trial could revolutionize Alzheimer’s treatment and screening, offering hope for improved early intervention and a brighter future for those at risk.

1 of 1

Story summary

At Royal Melbourne Hospital, researchers are pioneering a groundbreaking injectable drug, remternetug, designed to delay the onset of Alzheimer’s in individuals aged 65-80 exhibiting early symptoms. This global trial could revolutionize Alzheimer’s treatment and screening, offering hope for improved early intervention and a brighter future for those at risk.